New chemo regimen helps children with neuroblastoma
A new high-dose chemotherapy regimen has been shown to improve survival of children with high-risk neuroblastoma, a common pediatric cancer, according to a European clinical trial published Sunday.
A new high-dose chemotherapy regimen has been shown to improve survival of children with high-risk neuroblastoma, a common pediatric cancer, according to a European clinical trial published Sunday.
An anti-estrogen drug has shown a "promising" 65-percent reduction of breast cancer risk among post-menopausal women, according to the findings of a study released Saturday.